These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2382284)

  • 1. 15-Deoxyspergualin for induction of graft nonreactivity after cardiac and renal allotransplantation in primates.
    Reichenspurner H; Hildebrandt A; Human PA; Boehm DH; Rose AG; Odell JA; Reichart B; Schorlemmer HU
    Transplantation; 1990 Aug; 50(2):181-5. PubMed ID: 2382284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-Deoxyspergualin after cardiac and renal allotransplantation in primates.
    Reichenspurner H; Hildebrandt A; Human PA; Boehm DH; Rose AG; Schorlemmer HU; Reichart B
    Transplant Proc; 1990 Aug; 22(4):1618-9. PubMed ID: 2389423
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimalization of immunosuppression after xenogeneic heart transplantation in primates.
    Reichenspurner H; Human PA; Boehm DH; Rose AG; May R; Cooper DK; Zilla P; Reichart B
    J Heart Transplant; 1989; 8(3):200-7; discussion 207-8. PubMed ID: 2661769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of xenograft survival after combination therapy with 15-deoxyspergualin and total-lymphoid irradiation in the hamster-to-rat cardiac xenograft model.
    Marchman W; Araneda D; DeMasi R; Taylor D; Larkin E; Alqaisi M; Thomas F
    Transplantation; 1992 Jan; 53(1):30-4. PubMed ID: 1733081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of deoxyspergualin on vascular rejection in canine kidney transplantation.
    Tanabe K; Takahashi K; Nemoto K; Okada M; Yasuo M; Hayasaka Y; Toma H; Ota K
    J Urol; 1994 Aug; 152(2 Pt 1):562-6. PubMed ID: 8015112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood.
    Amada N; Okazaki H; Sato T; Ohashi Y; Kikuchi H
    Transplant Proc; 2005 Mar; 37(2):927-9. PubMed ID: 15848577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-Deoxyspergualin and primate heart transplantation.
    Kapelanski DP; Perelman MJ; Faber LA; Paez DE; Rose EF; Behrendt DM
    J Heart Transplant; 1990; 9(6):668-73; discussion 673-4. PubMed ID: 2277306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of cardiac xenograft rejection in primates.
    McManus RP; Kinney T; Komorowski R; Hunter J
    J Heart Lung Transplant; 1991; 10(4):567-76. PubMed ID: 1911800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat.
    Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H
    J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
    Wang J; Xu R; Jin R; Chen Z; Fidler JM
    Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a new immunosuppressant, 15-deoxyspergualin, on heterotopic rat heart transplantation, in comparison with cyclosporine.
    Suzuki S; Kanashiro M; Amemiya H
    Transplantation; 1987 Oct; 44(4):483-7. PubMed ID: 3313835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
    Waiser J; Slowinski T; Brinker-Paschke A; Budde K; Schreiber M; Böhler T; Hauser I; Neumayer HH
    Nephrol Dial Transplant; 2002 Jul; 17(7):1310-7. PubMed ID: 12105257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved results using OKT3 as induction immunosuppression in renal allograft recipients with delayed graft function.
    Benvenisty AI; Cohen D; Stegall MD; Hardy MA
    Transplantation; 1990 Feb; 49(2):321-7. PubMed ID: 2137654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic use of deoxyspergualin in a quadruple immunosuppressive protocol in renal transplantation.
    Koyama I; Amemiya H; Taguchi Y; Watanabe T; Nagashima N; Suzuki S; Omoto R
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1096-8. PubMed ID: 1989158
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L; Ding T; Wang XX; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G
    Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antilymphoblast globulin, cyclosporine, and steroids in cadaveric renal transplantation.
    Griño JM; Alsina J; Sabater R; Castelao AM; Gil-Vernet S; Andres E; Sabate I; Mestre M; Seron D; Diaz C
    Transplantation; 1990 Jun; 49(6):1114-7. PubMed ID: 2360253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.